{"count":220828,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=728","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=726","results":[{"created":"2022-10-06T13:27:42.178083+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.418","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NCF2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Chronic granulomatous disease 2, autosomal recessive, MIM# 233710; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCF2","entity_type":"gene"},{"created":"2022-10-06T13:27:13.550606+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.418","user_name":"David Amor","item_type":"entity","text":"reviewed gene: OCA2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Albinism, oculocutaneous, type II; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"OCA2","entity_type":"gene"},{"created":"2022-10-06T13:27:11.624170+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.418","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NCF1 as ready","entity_name":"NCF1","entity_type":"gene"},{"created":"2022-10-06T13:27:11.594830+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.418","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncf1 has been classified as Green List (High Evidence).","entity_name":"NCF1","entity_type":"gene"},{"created":"2022-10-06T13:27:07.705327+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.418","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NCF1 were set to ","entity_name":"NCF1","entity_type":"gene"},{"created":"2022-10-06T13:26:56.428744+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NCF1.","entity_name":"NCF1","entity_type":"gene"},{"created":"2022-10-06T13:26:40.960966+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NCF1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Chronic granulomatous disease 1, autosomal recessive, MIM# 233700; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCF1","entity_type":"gene"},{"created":"2022-10-06T13:26:09.304188+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NBN as ready","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:26:09.278108+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nbn has been classified as Red List (Low Evidence).","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:26:03.920495+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NBN as Red List (low evidence)","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:26:03.910431+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.417","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nbn has been classified as Red List (Low Evidence).","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:25:54.422775+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: NBN.","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:25:45.483535+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NBN: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Nijmegen breakage syndrome, MIM# 251260; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NBN","entity_type":"gene"},{"created":"2022-10-06T13:24:35.785610+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NAGS as ready","entity_name":"NAGS","entity_type":"gene"},{"created":"2022-10-06T13:24:35.775842+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nags has been classified as Green List (High Evidence).","entity_name":"NAGS","entity_type":"gene"},{"created":"2022-10-06T13:24:29.139288+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NAGS.","entity_name":"NAGS","entity_type":"gene"},{"created":"2022-10-06T13:24:20.518629+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NAGS: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: N-acetylglutamate synthase deficiency - MIM#237310; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NAGS","entity_type":"gene"},{"created":"2022-10-06T13:24:00.309477+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"David Amor","item_type":"entity","text":"reviewed gene: OBSL1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: 3-M syndrome 2; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"OBSL1","entity_type":"gene"},{"created":"2022-10-06T13:23:45.591991+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NAGLU as ready","entity_name":"NAGLU","entity_type":"gene"},{"created":"2022-10-06T13:23:45.583460+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: naglu has been classified as Green List (High Evidence).","entity_name":"NAGLU","entity_type":"gene"},{"created":"2022-10-06T13:23:41.908911+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.416","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NAGLU were changed from Sanfilippo syndrome type B to Mucopolysaccharidosis type IIIB (Sanfilippo B), MIM# 252920","entity_name":"NAGLU","entity_type":"gene"},{"created":"2022-10-06T13:23:28.010455+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.415","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: NAGLU.","entity_name":"NAGLU","entity_type":"gene"},{"created":"2022-10-06T13:23:19.628327+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.415","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NAGLU: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Mucopolysaccharidosis type IIIB (Sanfilippo B), MIM# 252920; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NAGLU","entity_type":"gene"},{"created":"2022-10-06T13:22:24.360663+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.415","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NAGA as ready","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:22:24.351128+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.415","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: naga has been classified as Red List (Low Evidence).","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:22:21.052192+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.415","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NAGA were changed from N-acetylgalactosaminidase alpha deficiency to Kanzaki disease, MIM# 609242","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:22:06.828823+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.414","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NAGA as Red List (low evidence)","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:22:06.807548+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.414","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: naga has been classified as Red List (Low Evidence).","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:21:52.229194+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.413","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NAGA: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Kanzaki disease, MIM# 609242; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NAGA","entity_type":"gene"},{"created":"2022-10-06T13:20:38.971313+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.413","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYO9A as ready","entity_name":"MYO9A","entity_type":"gene"},{"created":"2022-10-06T13:20:38.955423+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.413","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo9a has been classified as Red List (Low Evidence).","entity_name":"MYO9A","entity_type":"gene"},{"created":"2022-10-06T13:20:27.367673+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.413","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYO9A as Red List (low evidence)","entity_name":"MYO9A","entity_type":"gene"},{"created":"2022-10-06T13:20:27.359403+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.413","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo9a has been classified as Red List (Low Evidence).","entity_name":"MYO9A","entity_type":"gene"},{"created":"2022-10-06T13:20:13.306050+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.412","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYO9A: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Myasthenic syndrome, congenital, 24, presynaptic (MIM# 618198); Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MYO9A","entity_type":"gene"},{"created":"2022-10-06T13:19:36.660360+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.412","user_name":"David Amor","item_type":"entity","text":"edited their review of gene: NEU1: Changed rating: RED","entity_name":"NEU1","entity_type":"gene"},{"created":"2022-10-06T13:18:30.660315+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.412","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYO7A as ready","entity_name":"MYO7A","entity_type":"gene"},{"created":"2022-10-06T13:18:30.650181+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.412","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo7a has been classified as Green List (High Evidence).","entity_name":"MYO7A","entity_type":"gene"},{"created":"2022-10-06T13:18:27.264345+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.412","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYO7A were changed from Usher syndrome to Deafness, autosomal recessive 2, 600060; Usher syndrome, type 1B, MIM# 276900","entity_name":"MYO7A","entity_type":"gene"},{"created":"2022-10-06T13:18:09.352191+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.411","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYO7A: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal recessive 2, 600060, Usher syndrome, type 1B, MIM# 276900; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MYO7A","entity_type":"gene"},{"created":"2022-10-06T13:17:09.542052+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.411","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYO6 as ready","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:17:09.531915+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.411","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo6 has been classified as Green List (High Evidence).","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:17:01.961087+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.411","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYO6 were changed from Deafness to Deafness, autosomal dominant 22, MIM# 606346; Deafness, autosomal recessive 37, MIM# 607821","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:16:50.997545+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.410","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MYO6 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:16:38.410781+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.409","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: MYO6.","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:16:30.389998+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.409","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYO6: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal dominant 22, MIM# 606346, Deafness, autosomal recessive 37, MIM# 607821; Mode of inheritance: BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"MYO6","entity_type":"gene"},{"created":"2022-10-06T13:15:18.454710+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.409","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYO3A as ready","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:15:18.437036+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.409","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo3a has been classified as Red List (Low Evidence).","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:15:15.289749+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.409","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYO3A were changed from Sensorineural hearing loss to Deafness, autosomal recessive 30, MIM:607101","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:14:58.078614+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.408","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYO3A as Red List (low evidence)","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:14:58.069977+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.408","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo3a has been classified as Red List (Low Evidence).","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:14:46.857971+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.407","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYO3A: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal recessive 30 OMIM:607101; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MYO3A","entity_type":"gene"},{"created":"2022-10-06T13:14:07.762661+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.407","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYO15A as ready","entity_name":"MYO15A","entity_type":"gene"},{"created":"2022-10-06T13:14:07.745597+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.407","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myo15a has been classified as Green List (High Evidence).","entity_name":"MYO15A","entity_type":"gene"},{"created":"2022-10-06T13:14:01.342404+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.407","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYO15A were changed from Sensorineural hearing loss to Deafness, autosomal recessive 3, MIM# 600316","entity_name":"MYO15A","entity_type":"gene"},{"created":"2022-10-06T13:13:43.551312+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.406","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYO15A: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal recessive 3, MIM# 600316; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MYO15A","entity_type":"gene"},{"created":"2022-10-06T13:13:05.979007+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.406","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH9 as ready","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:13:05.970381+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.406","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh9 has been classified as Red List (Low Evidence).","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:13:02.275948+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.406","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYH9 were changed from Macrothrombocytopenia and progressive sensorineural deafness to Deafness, autosomal dominant 17, MIM# 603622; Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, MIM# 155100","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:12:48.563501+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.405","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH9 as Red List (low evidence)","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:12:48.555335+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.405","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh9 has been classified as Red List (Low Evidence).","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:12:36.184502+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.404","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYH9: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal dominant 17, MIM# 603622, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, MIM# 155100; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYH9","entity_type":"gene"},{"created":"2022-10-06T13:11:41.967919+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.404","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH7 as ready","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:11:41.957714+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.404","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh7 has been classified as Red List (Low Evidence).","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:11:31.876532+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.404","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MYH7 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:11:20.857889+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.403","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH7 as Red List (low evidence)","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:11:20.849967+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.403","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh7 has been classified as Red List (Low Evidence).","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:11:09.189051+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.402","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYH7: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Cardiomyopathy, dilated, 1S, MIM# 613426 MONDO:0013262, Cardiomyopathy, hypertrophic, 1, MIM# 192600, Laing distal myopathy, MIM# 160500, Myopathy, myosin storage, autosomal dominant, MIM# 608358, Myopathy, myosin storage, autosomal recessive, MIM# 255160; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"MYH7","entity_type":"gene"},{"created":"2022-10-06T13:10:01.259542+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.402","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH3 as ready","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:10:01.250640+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.402","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh3 has been classified as Red List (Low Evidence).","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:09:54.507984+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.402","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYH3 were changed from Arthrogryposis, distal to Arthrogryposis, distal, type 2A (Freeman-Sheldon) 193700; Arthrogryposis, distal, type 2B3 (Sheldon-Hall) 618436; Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A 178110; Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B 618469","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:09:41.889330+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.401","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MYH3 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:09:33.307162+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.400","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH3 as Red List (low evidence)","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:09:33.299456+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.400","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh3 has been classified as Red List (Low Evidence).","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:09:22.491847+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.399","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYH3: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Arthrogryposis, distal, type 2A (Freeman-Sheldon) 193700, Arthrogryposis, distal, type 2B3 (Sheldon-Hall) 618436, Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A 178110, Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B 618469; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"MYH3","entity_type":"gene"},{"created":"2022-10-06T13:08:23.102240+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.399","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH2 as ready","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:08:23.094036+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.399","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh2 has been classified as Red List (Low Evidence).","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:08:19.490505+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.399","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYH2 were changed from Proximal myopathy and ophthalmoplegia to Proximal myopathy and ophthalmoplegia, MIM# 605637","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:08:03.722107+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.398","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH2 as Red List (low evidence)","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:08:03.714761+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.398","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh2 has been classified as Red List (Low Evidence).","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:07:52.747882+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.397","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYH2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Proximal myopathy and ophthalmoplegia, MIM# 605637; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MYH2","entity_type":"gene"},{"created":"2022-10-06T13:07:15.781188+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.397","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYH14 as ready","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:07:15.768682+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.397","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh14 has been classified as Red List (Low Evidence).","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:07:12.294280+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.397","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYH14 were changed from Deafness, autosomal dominant to Deafness, autosomal dominant 4A, MIM# 600652; Peripheral neuropathy, myopathy, hoarseness, and hearing loss 614369","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:07:00.290243+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.396","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MYH14 were set to ","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:06:50.549728+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.395","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYH14 as Red List (low evidence)","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:06:50.539603+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.395","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: myh14 has been classified as Red List (Low Evidence).","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:06:38.859304+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.394","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYH14: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal dominant 4A, MIM# 600652, Peripheral neuropathy, myopathy, hoarseness, and hearing loss 614369; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYH14","entity_type":"gene"},{"created":"2022-10-06T13:05:51.697718+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.394","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYCN as ready","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:05:51.687996+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.394","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mycn has been classified as Red List (Low Evidence).","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:05:44.713404+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.394","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MYCN were changed from Feingold syndrome to Feingold syndrome 1, MIM# 164280","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:04:07.540477+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.393","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYCN as Red List (low evidence)","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:04:07.532132+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.393","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mycn has been classified as Red List (Low Evidence).","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:03:55.301361+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.392","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYCN: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Feingold syndrome 1, MIM# 164280; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MYCN","entity_type":"gene"},{"created":"2022-10-06T13:03:15.870581+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.392","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MYBPC1 as ready","entity_name":"MYBPC1","entity_type":"gene"},{"created":"2022-10-06T13:03:15.862389+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.392","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mybpc1 has been classified as Red List (Low Evidence).","entity_name":"MYBPC1","entity_type":"gene"},{"created":"2022-10-06T13:02:57.161018+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.392","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MYBPC1 as Red List (low evidence)","entity_name":"MYBPC1","entity_type":"gene"},{"created":"2022-10-06T13:02:57.145119+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.392","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mybpc1 has been classified as Red List (Low Evidence).","entity_name":"MYBPC1","entity_type":"gene"},{"created":"2022-10-06T13:02:45.211806+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.391","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MYBPC1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Arthrogryposis, distal, type 1B 614335, Lethal congenital contracture syndrome 4, MIM# 614915; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"MYBPC1","entity_type":"gene"},{"created":"2022-10-06T13:01:43.756768+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.391","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MVK as ready","entity_name":"MVK","entity_type":"gene"},{"created":"2022-10-06T13:01:43.747758+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.391","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mvk has been classified as Green List (High Evidence).","entity_name":"MVK","entity_type":"gene"}]}